SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-17-000190
Filing Date
2017-01-13
Accepted
2017-01-13 14:13:34
Documents
73
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 365512
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 6898
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 6951
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2984
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3119
12 GRAPHIC bunkasig.jpg GRAPHIC 2367
13 GRAPHIC dochertysig.jpg GRAPHIC 1572
  Complete submission text file 0001062993-17-000190.txt   4361333

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lxrp-20161130.xml EX-101.INS 397378
7 XBRL SCHEMA FILE lxrp-20161130.xsd EX-101.SCH 152052
8 XBRL CALCULATION FILE lxrp-20161130_cal.xml EX-101.CAL 43958
9 XBRL DEFINITION FILE lxrp-20161130_def.xml EX-101.DEF 430405
10 XBRL LABEL FILE lxrp-20161130_lab.xml EX-101.LAB 948200
11 XBRL PRESENTATION FILE lxrp-20161130_pre.xml EX-101.PRE 481219
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52138 | Film No.: 17527389
SIC: 1000 Metal Mining